4.2 Article

Brief Cognitive-Behavioral Therapy for Suicidal Inpatients

Journal

COGNITIVE AND BEHAVIORAL PRACTICE
Volume 28, Issue 2, Pages 224-240

Publisher

ELSEVIER SCIENCE INC

Keywords

suicide; treatment; hospitalized; cognitive behavioral

Funding

  1. Institute of Living Depression Initiative Fund [126555]
  2. Pfizer
  3. Palo Alto Health Services, Inc.

Ask authors/readers for more resources

Suicide risk is higher in psychiatric patients after discharge from inpatient care, but there is limited research on suicide prevention protocols specifically designed for this setting. This study modified brief cognitive-behavioral therapy (BCBT) for inpatients (BCBT-I) and found it to be highly acceptable and effective in reducing suicidal ideation and depression. Further research is needed to validate BCBT-I in a larger, randomized controlled trial to assess its efficacy in reducing suicide risk in this population.
Suicide risk is elevated in psychiatric patients following discharge from inpatient care. Despite this vulnerability, there has been limited research investigating suicide prevention protocols that take into account the unique system characteristics of this setting (e.g., short lengths of stay, crisis stabilization treatment model, multidisciplinary team coordination). Cognitive-behavioral therapy (CBT) has demonstrated efficacy for improving suicide risk in outpatients, but has not been validated with inpatients. The current study was a treatment development and pilot feasibility open trial that modified brief cognitive-behavioral therapy (BCBT) for an inpatient setting (BCBT-I). Key treatment modifications included administering up to 10 sessions (depending on patient length of stay), daily, and in a standardized order, with core crisis management skills introduced during the first three sessions. In addition, coordination with the inpatient treatment team was included in BCBT-I implementation. Six adult inpatients with a recent suicide attempt enrolled and completed an average of 4.67 BCBT-I sessions (SD = 1.36). The treatment was highly acceptable (Client Satisfaction Questionnaire total score M = 3.49, SD = 0.73). Pre-to posttreatment effect sizes demonstrated improvements in suicidal ideation (d = 0.97), depression (d = 1.33), and suicidal implicit associations (d = 1.28). All but one of the participants (83%) completed follow-up assessments 1-, 2-, and 3-months postdischarge. Over follow-up, two participants reported suicidal ideation (both without intent), and none reported suicide attempts, preparatory acts or behaviors, or nonsuicidal self injury. This study provided preliminary evidence supporting the feasibility of CBT to treat suicidal inpatients. Future research is needed to validate BCBT-I in a larger, randomized controlled trial to determine whether BCBT-I reduces suicide risk beyond that afforded by inpatient treatment alone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available